Research Paper Volume 13, Issue 6 pp 8155—8176
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
Figure 4. Calibration curve for predicting the probability of 1-, 3- and 5-year OS for LUAD patients. (A–D) The calibration curve of the nomogram in LUAD from TCGA data.